HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Use of cerebrospinal fluid CXCL10 and neopterin as biomarkers in HTLV-1-associated myelopathy/tropical spastic paraparesis treated with steroids.

AuthorsJunji Yamauchi, Tomoo Sato, Naoko Yagishita, Natsumi Araya, Daisuke Hasegawa, Shuntaro Tsutsumi, Misako Nagasaka, Ariella Coler-Reilly, Eisuke Inoue, Ayako Takata, Yasuhiro Hasegawa, Yoshihisa Yamano
JournalJournal of neurology, neurosurgery, and psychiatry (J Neurol Neurosurg Psychiatry) Vol. 91 Issue 3 Pg. 321-323 (03 2020) ISSN: 1468-330X [Electronic] England
PMID31662348 (Publication Type: Letter, Research Support, Non-U.S. Gov't)
Chemical References
  • Biomarkers
  • CXCL10 protein, human
  • Chemokine CXCL10
  • Glucocorticoids
  • Neopterin
  • Prednisolone
Topics
  • Biomarkers (cerebrospinal fluid)
  • Chemokine CXCL10 (cerebrospinal fluid)
  • Glucocorticoids (therapeutic use)
  • Human T-lymphotropic virus 1
  • Humans
  • Neopterin (cerebrospinal fluid)
  • Paraparesis, Tropical Spastic (cerebrospinal fluid, drug therapy)
  • Prednisolone (therapeutic use)
  • Retrospective Studies
  • Treatment Outcome

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: